Hybrid Treatment of Complex Thoracic Aortic Aneurysm
Marijan Koprivanac, MD, discusses open hybrid treatment of complex thoracic aortic aneurism in a high-risk octogenarian patient.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Recent Episodes
Lepodisiran and the Emerging Role of Oxidized Phospholipids in Lipoprotein(a) Risk
Luke Laffin, MD, speaks with Steven Nissen, MD, about findings from the ALPACA trial evaluating lepodisiran and its effects on oxidized phos…
Talking Tall Rounds®: Updates on Less Invasive Cardiac Surgery
In this excerpt from Tall Rounds®, Gianluca Torregrossa, MD, discusses minimally invasive and totally endoscopic coronary artery bypass graf…
CTX310 and the Future of Gene Editing for Lipid Disorders
Steven Nissen, MD, and Luke Laffin, MD, discuss one-year follow-up data for CTX310, a CRISPR-Cas9 gene-editing therapy targeting ANGPTL3 to…
Video content: This video is available to watch online.
View video online (https://cdnapisec.kaltura.com/p/2207941/sp/220794100/playManifest/entryId/1_g7cn4pav/flavorId/1_5f3sgelj/format/url/protocol/https/a.mp4)
Transcript
Announcer:
Welcome to Cleveland Clinic Cardiac Consult brought to you by the Sydell & Arnold Miller Family Heart, Vascular & Thoracic Institute at Cleveland Clinic.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Marijan Koprivanac, MD:
The patient is a 83 years old, frail female, on two liters of oxygen at home, with significant medical history of diabetes and obesity. Incidentally, ascending-descending aortic aneurysm is found after a total right knee replacement, complicated by a pulmonary embolism. CTA angiogram showed a proximal descending aortic aneurysm of 6.2 centimeters and ascending aorta of 5.2 centimeters. Arch diameter was 3.5 and relatively normal in zone two. Echo showed normal LV and RV function and size. There are no significant valvular abnormalities. Central cannulation is performed. The right atrium is cannulated, and an extra cannula is placed in the SVC for retrograde brain perfusion. Retrograde cardioplegia cannula is placed. Aorta pulmonary window is dissected. Cross-clamp is applied. Cardiopulmonary bypass is initiated to start cooling. Head vessels are dissected and exposed. The ascending aorta is divided above the sinotubular junction. The lesser curvature and aortic root are mobilized to maximize efficiency and minimize cardiopulmonary bypass exposure.
Extra aortic wall is removed below the sinotubular junction at non-coronary sinus to exclude more aortic tissue. Aortic valve is assessed for significant fenestrations or calcifications. Cross suspension and stitches are placed. The left atrial appendage clip is deployed. Patient is cooled to the level of deep hypothermia. SVC is narrowly supplied, and circulatory arrest is initiated using retrograde perfusion. The distal ascending aorta is transected. The arch is inspected for tears and backflow from the head vessels. The whole arch is mobilized. The decision is made to perform the B-SAFER technique introduced by Dr. Roselli. A 40 by 10 centimeter stent graft is delivered antegrade into the descending aorta under direct vision. Based on tissue quality assessment and arch disease, the device is deployed and positioned in zone one. The main body is sutured to the lesser curvature and pulled downwards to allow a better manipulation of the arch. A five to 10 millimeter hole is cut into the stent graft and dilated with a clamp. A 13 by 2.5 centimeter branch vessel stent graft is delivered directly through the hole, into the left subclavian artery over a wire. To avoid further intimal injury, the device is dilated by using two methods; with a right angle clamp and with a nine-French Pruitt balloon catheter. Retrograde brain perfusion is stopped and antegrade perfusion is started through the nominate and left subclavian arteries. An additional fenestration with a branch stent graft is placed into the left carotid artery. A 10.5 centimeter stent component is deployed with five to 10 millimeters extending into the aortic lumen. A Pruitt balloon catheter is placed and antegrade brain profusion is continued. The aortic stent graft is circumferentially sutured to the aortic wall with a continued horizontal mattress suture and leaving a rim of the aortic wall.
Advertisement
The suture line is continued behind the nominate artery. The redundant aortic tissue is excised. A conventional single branch surgical graft is beveled and sewn to the arch using imbricated vertical mattress sutures in the posterior wall for hemostasis. The transition from the graft to the nominate artery is carefully sutured, re-implanting the innominate artery to the suture line. All three Pruitts are removed. The 10 millimeter branch is connected to the arterial line, and systemic perfusion is initiated slowly. Simultaneously, high power suction is applied to the head vessels and arch. The graft is unclamped and open to the field to start the healing process. Hemostasis is checked and the rewarming of the patient is started. The coaptation of the aortic valve is checked one more time, and the proximal end of the graft is beveled. A rim of supracommissural aortic wall is left and incorporated into the proximal anastomosis to increase overlapped and hemostasis.
Cross clamp is removed and small earring holes are performed. A total of 24 minutes of deep hypothermic circulatory arrest with retrograde and antegrade cerebral perfusion. Patient is extubated on postoperative day number one. Operative day number seven, patient went to the step down unit and discharged to a skilled nurse facility after three weeks. On postoperative day number 40, patient went home from this SNF. The postoperative CT angiogram showed the surgical graft of the ascending aorta, the arch that continues as a frozen elephant trunk to the level of the mid descending aorta. Root size change from 3.8 to 3.3 centimeter. No evidence of complications such as anastomotic and stenosis, endoleak, or pseudoaneurysm formation. Thank you.
Announcer:
Thank you for listening. We hope you enjoyed the podcast. We welcome your comments and feedback. Please contact us at heart@ccf.org. Like what you heard? Subscribe wherever you get your podcasts or listen at clevelandclinic.org/cardiacconsultpodcast.
Advertisement
Recent Episodes
Lepodisiran and the Emerging Role of Oxidized Phospholipids in Lipoprotein(a) Risk
Luke Laffin, MD, speaks with Steven Nissen, MD, about findings from the ALPACA trial evaluating lepodisiran and its effects on oxidized phos…
Talking Tall Rounds®: Updates on Less Invasive Cardiac Surgery
In this excerpt from Tall Rounds®, Gianluca Torregrossa, MD, discusses minimally invasive and totally endoscopic coronary artery bypass graf…
CTX310 and the Future of Gene Editing for Lipid Disorders
Steven Nissen, MD, and Luke Laffin, MD, discuss one-year follow-up data for CTX310, a CRISPR-Cas9 gene-editing therapy targeting ANGPTL3 to…
Never miss a moment - subscribe now.
Listen to the Health Essentials Podcast on your favorite streaming platform.
Other Podcasts You May Love
Butts & Guts
A Cleveland Clinic podcast exploring your digestive and surgical health from end to end. You’ll lear…
Health Essentials
Tune in for practical health advice from Cleveland Clinic experts. What's really the healthiest diet…
Love Your Heart
A Cleveland Clinic podcast to help you learn more about heart and vascular disease and conditions af…
Neuro Pathways
A Cleveland Clinic podcast for medical professionals exploring the latest research discoveries and c…